Epidural Analgesia Versus IV Meperidine for Labor Pain Control

Epidural Analgesia Versus IV Meperidine for Labor Pain Control. Objective Evaluation of the Pain Intensity Influence on the Autonomic Nervous System.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00296751

Enrollment

Registered

2006-02-27

Start date

2006-03-31

Completion date

2006-12-31

Last updated

2010-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor Pain

Brief summary

60 female that care for pain control during second stage of delivery, will choose between epidural or systemic analgesia. Continuous ECG (3 lead)monitoring will be recorded during the second stage for 10 minutes. 30 minutes after administration of either pain relief, a second recording of maternal ECG will take place for 10 minutes.

Detailed description

Population 60 female during second stage of delivery * Inclusion criteria : all parturients requiring pain relief will choose between systemic or epidural analgesia. * Exclusion Criteria: all parturients with cardiac disease, neurological disease, endocrine disease, diabetes, hypertension or any parturients being treated with medications that might effect the cardiovascular autonomic system. * Method: A 10 minute recording of a 3 lead ECG will be performed during the second stage of the delivery (3-7 CM opening). the parturient will be lying on her left side for that period. * 30 minutes after administration of either epidural or systemic Meperidine for pain relief, a second recording of maternal ECG will take place for 10 minutes. * estimated duration of the procedure about one hour per woman.

Interventions

PROCEDUREECG recording

PROCEDUREEpidural catheter insertion

DRUGIntravenous meperidine injection

DRUGEpidural Bupivacaine and fentanyl injection

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

20 Years to 40 Years

Healthy volunteers

Yes

Inclusion criteria

all parturients requiring pain relief will choose between systemic or epidural analgesia.

Exclusion criteria

all parturients with cardiac disease, neurological disease, endocrine disease, diabetes, hypertension or any parturients being treated with medications that might effect the cardiovascular or autonomic system. \-

Design outcomes

Primary

Measure	Time frame
Three lead ECG monitoring for 10 minutes will be performed 30 minutes after the administration.	—

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026